In the News
First Patient Dosed with Telix's 68-Ga-PSMA-11 Imaging Agent, Illuccix
Telix Launches Medical Education Platform with Applied Radiology
Telix Launches Gallium Awareness Website
Telix Signs Distribution Agreement with Eckert & Ziegler
Telix, Grand River Aseptic Complete Agreement for Commercial Manufacturing of Illuccix
Nuclear Medicine Prepares for Greater Ga 68 Demand
Telix to Start Phase 1 Clinical Trial of Prostate Cancer Imaging Product in Japan
Telix & Grand Pharma China Announce Partnership for MTR Products
Telix Submits FDA Drug Application for Prostate Cancer PET Imaging
Telix Partners with Varian to Improve Advanced Prostate Imaging Treatment
Telix Receives FDA Breakthrough Therapy Designation for Renal Cancer
